Shortened LSD treatment for major depression
Treatments studied
Part of Mental health clinical trials.
This study tests a shortened version of LSD therapy for people with major depressive disorder. It aims to see if a brief intervention can quickly reduce depressive symptoms and is designed for people who are not responding to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with major depressive disorder (also called clinical depression).
- You are willing to stop taking certain medications for depression or other conditions before the study.
- You are not pregnant, nursing, or planning to become pregnant during the trial.
- You do not have serious heart problems, epilepsy, or a history of stroke or mini-stroke.
- You are not severely obese (a body mass index, or BMI, of 40 or higher).
- You have no history of schizophrenia, bipolar disorder, or depression with psychosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether an LSD treatment approach, combined with study procedures, can help people with moderate-to-severe alcohol use disorder cut down or stop drinking. It may help reset patterns around cravings and drinking, but it also requires careful safety screening.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This Phase 2 study tests how LSD may affect comfort and quality of life for people with advanced or end-stage life-limiting illness. It also checks whether the medicine is safe and can be given in a controlled way in palliative care settings.
Hear when a new Major Depression Moderate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.